Home > Boards > US Listed > Medical - Equipment > Guardion Health Sciences Inc. (GHSI)

The way this moves, the extra 1.25 million

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
go2sleepjj Member Profile
 
Followed By 99
Posts 2,292
Boards Moderated 0
Alias Born 07/14/15
160x600 placeholder
Guardion Health Sciences, Inc. Reports Results for the Three and Nine Months Ended September 30, 2019 GlobeNewswire Inc. - 11/14/2019 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/13/2019 5:27:30 PM
Guardion Health Sciences Closes $8.4 Million Underwritten Public Offering GlobeNewswire Inc. - 10/30/2019 12:33:22 PM
Guardion Health Sciences Announces Pricing of $8.4 Million Underwritten Public Offering GlobeNewswire Inc. - 10/28/2019 9:21:39 AM
Guardion® Receives approval from USPTO for expanded claims for its Proprietary Medical Device, the MAPCAT SF GlobeNewswire Inc. - 10/23/2019 7:00:05 AM
Guardion® Announces Statistically Significant Blood Assay Study Results GlobeNewswire Inc. - 10/10/2019 10:30:00 AM
Guardion Health Sciences Acquires the NutriGuard Brand of Products GlobeNewswire Inc. - 9/23/2019 10:30:00 AM
Guardion Launches VectorVision CSV-2000 Standardized Contrast Sensitivity Test GlobeNewswire Inc. - 9/3/2019 7:00:00 AM
Guardion Health Sciences Closes $5.8 Million Underwritten Public Offering GlobeNewswire Inc. - 8/15/2019 4:05:00 PM
Guardion Health Sciences Announces an Increase in the Pricing of its Previously Announced Underwritten Public Offering GlobeNewswire Inc. - 8/15/2019 8:35:14 AM
Guardion Health Sciences Announces Pricing of $5.2 Million Underwritten Public Offering GlobeNewswire Inc. - 8/13/2019 9:00:00 AM
Guardion Health Sciences Reports June 30, 2019 Interim Results of Operations GlobeNewswire Inc. - 8/12/2019 8:40:00 AM
Foundation Fighting Blindness selects Guardion’s VectorVision CSV-1000 Diagnostic Instrument for Use in Large-Scale Multi-C... GlobeNewswire Inc. - 8/6/2019 7:00:00 AM
Guardion’s Proprietary Medical Device, the MapcatSF®, Receives Patent from the Hong Kong Patents Registry GlobeNewswire Inc. - 7/17/2019 7:00:00 AM
Guardion’s Proprietary Medical Device, the MapcatSF®, Receives Patent from the European Union GlobeNewswire Inc. - 6/20/2019 7:00:00 AM
Guardion Launches Second Ocular Health Formula ‘GlaucoCetin’ GlobeNewswire Inc. - 6/4/2019 7:00:00 AM
Guardion’s Lumega-Z Formula Associated with Substantial Clinical Improvement in Patients Contrast Sensitivity Visual Functi... GlobeNewswire Inc. - 5/9/2019 10:14:43 AM
Guardion's Lumega-Z Formula Associated with Improved Vision in Patients with Severe Glaucoma GlobeNewswire Inc. - 5/7/2019 7:00:00 AM
Guardion Health Sciences, Inc. Receives Official Trademark Registrations in China GlobeNewswire Inc. - 5/1/2019 7:00:00 AM
Results of Lumega-Z Data to be Presented at ARVO GlobeNewswire Inc. - 4/17/2019 9:01:23 AM
WallachBeth Capital Announces Completion of the $5 Million IPO for Guardion Health Services PR Newswire (US) - 4/11/2019 9:18:00 AM
Guardion Health Sciences, Inc. Announces Closing of Initial Public Offering GlobeNewswire Inc. - 4/9/2019 12:20:13 PM
Guardion Health Sciences, Inc. Announces Pricing of Initial Public Offering Business Wire - 4/5/2019 12:49:00 PM
go2sleepjj   Sunday, 09/29/19 11:13:55 AM
Re: JohnConnor67 post# 300
Post # of 376 
The way this moves, the extra 1.25 million shares are going to get chomped on by lunchtime and then there will be a full on running of the bulls back up to IPO price. Other than the underwriters cashing in their shares, insiders aren’t going to want to exercise their options so low when they know they can sell at much higher.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist